Prediction and Evaluation of Anlotinib Treatment Response Using Contrast Enhanced Ultrasound PPGL Patients

NCT06015061 · clinicaltrials.gov ↗

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Pheochromocytoma, Metastatic
Ultrasonography
Paraganglioma, Malignant
Pheochromocytoma Malignant

Interventions

DIAGNOSTIC_TEST: Contrast-enhanced ultrasound(CEUS)

Sponsor

Peking Union Medical College Hospital